Skip to main content

Dr. Lee Resta, M.D.

Hematology & Oncology (Hematology & Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
27
In the NPI registry since
2006
Medicare patients seen, 2024
691

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1999Medical school: Duke University School of Medicine
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    VA license 0101242990
  • Internal Medicine Physician
    HI license MD13131 · MA license 219131 · MD license D0063734 · PA license MD425365

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
691
Services billed
153,764
Patients’ average age
75
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, pembrolizumab, 1 mg12,50034
Injection, aprepitant, 1 mg12,48053
Injection, oxaliplatin, 0.5 mg8,00013
Injection, daratumumab, 10 mg and hyaluronidase-fihj7,02013
Injection, paclitaxel, 1 mg6,03620
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg2,69017
Injection, dexamethasone sodium phosphate, 1 mg2,22091
Injection, denosumab, 1 mg1,86012
Injection, bortezomib, 0.1 mg1,22512
Injection, palonosetron hcl, 25 mcg1,20060

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 6 companies reported 6 payments worth $120 in total to this clinician.

By company
Novartis Pharmaceuticals Corporation$24.29
Celgene Corporation$21.71
EMD Serono, Inc.$21.36
Janssen Biotech, Inc.$18.98
Array Biopharma Inc$17.18
Pfizer Inc.$16.23
By type
Food and Beverage$120

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Virginia →

Other Hematology & Oncology clinicians in Winchester

Sources

NPI registry (CMS NPPES, November 2026; record last updated May 24, 2023), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1003882432. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.